Finasteride in Treating Patients With Stage II Prostate Cancer Who Are Undergoing Surgery
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well finasteride works in treating patients with
stage II prostate cancer who are undergoing surgery. Testosterone can cause the growth of
prostate cancer cells. Hormone therapy using finasteride may fight prostate cancer by
lowering the amount of testosterone the body makes. Giving finasteride before surgery may
make the tumor smaller and reduce the amount of normal tissue that needs to be removed.